M Larsabal1, S Ly1,2,3, E Sbidian3,4,5, M Moyal-Barracco2,6, J-N Dauendorffer2,3,7, N Dupin6,8, M A Richard3,9, O Chosidow3,4,5,8, M Beylot-Barry1,3. 1. Department of Dermatology, Bordeaux University Hospital, Bordeaux University, Bordeaux, France. 2. Vulvology Study Group of the French Society for Dermatology, Maison de la Dermatologie, Malherbes, Paris, France. 3. Psoriasis Research Group of the French Society for Dermatology, Maison de la Dermatologie, Malherbes, Paris, France. 4. Department of Dermatology, Henri-Mondor Hospital, Public Assistance - Paris Hospitals (AP-HP), Créteil, France. 5. Virus,Immunity and Cancer University-Hospital Complex (DHU VIC), EA 7379 Epidemiology in Dermatology and Evaluation of Treatments (EpiDermE), Paris-Est University Créteil (UPEC), Créteil, France. 6. Department of Dermatology, Cochin Tarnier Hospital, Paris Descartes University, Paris, France. 7. Department of Dermatology, Saint-Louis Hospital, Paris, France. 8. Dermatological Infectiology and Sexually Transmitted Diseases Group of the French Society for Dermatology, Maison de la Dermatologie, Malherbes, Paris, France. 9. Department of Dermatology, Timone Hospital, Public Assistance-Marseille Hospitals, Aix-Marseille University, UMR 911, INSERM CRO2, "Centre de recherche en oncologie biologique et oncopharmacologie", Marseille, France.
Abstract
BACKGROUND: Genital psoriasis is often under-recognized. OBJECTIVES: To assess the instantaneous prevalence of genital psoriasis and describe its clinical features, association with a particular subtype of psoriasis and its impact on general and sexual quality of life (QoL). METHODS: GENIPSO is a prospective study conducted by private and hospital-based dermatologists. This study featured the consecutive inclusion of patients consulting for extragenital psoriasis. The clinical features of psoriasis and genital psoriasis were recorded and QoL and sexual health questionnaires were distributed to patients. RESULTS: Overall, 335 of 776 patients (43·2%) included in the study had genital involvement. All were aware that they had genital lesions but only 135 patients (40%) declared that they had been previously examined. Genital lesions were associated with male sex, severity of psoriasis, age of onset > 20 years, inverse psoriasis and involvement of scalp, nail and external auditory canal, but were not associated with obesity, psoriatic arthritis and active sex life. Itching was the main symptom. Genital psoriasis was associated with impairment of QoL and sexual health according to the Dermatology Life Quality Index and the Female Sexual Function Index. CONCLUSIONS: Genital psoriasis has a high prevalence in patients consulting for extragenital psoriasis, which affects QoL, and should be taken into account by dermatologists in order to optimize global care.
BACKGROUND:Genital psoriasis is often under-recognized. OBJECTIVES: To assess the instantaneous prevalence of genital psoriasis and describe its clinical features, association with a particular subtype of psoriasis and its impact on general and sexual quality of life (QoL). METHODS: GENIPSO is a prospective study conducted by private and hospital-based dermatologists. This study featured the consecutive inclusion of patients consulting for extragenital psoriasis. The clinical features of psoriasis and genital psoriasis were recorded and QoL and sexual health questionnaires were distributed to patients. RESULTS: Overall, 335 of 776 patients (43·2%) included in the study had genital involvement. All were aware that they had genital lesions but only 135 patients (40%) declared that they had been previously examined. Genital lesions were associated with male sex, severity of psoriasis, age of onset > 20 years, inverse psoriasis and involvement of scalp, nail and external auditory canal, but were not associated with obesity, psoriatic arthritis and active sex life. Itching was the main symptom. Genital psoriasis was associated with impairment of QoL and sexual health according to the Dermatology Life Quality Index and the Female Sexual Function Index. CONCLUSIONS:Genital psoriasis has a high prevalence in patients consulting for extragenital psoriasis, which affects QoL, and should be taken into account by dermatologists in order to optimize global care.
Authors: Marloes E van Muijen; Tamara W van Hal; Hans M M Groenewoud; Juul M P A van den Reek; Elke M G J de Jong Journal: Psoriasis (Auckl) Date: 2020-10-05
Authors: Neuza da Silva; Matthias Augustin; Anna Langenbruch; Ulrich Mrowietz; Kristian Reich; Diamant Thaçi; Wolf-Henning Boehncke; Natalia Kirsten; Alexandra Danckworth; Rachel Sommer Journal: PLoS One Date: 2020-07-01 Impact factor: 3.240
Authors: J F Merola; P-D Ghislain; J N Dauendorffer; A Potts Bleakman; A J M Brnabic; R Burge; E Riedl Journal: J Eur Acad Dermatol Venereol Date: 2020-02-05 Impact factor: 6.166
Authors: Ranjitha Uppala; Lam C Tsoi; Paul W Harms; Bo Wang; Allison C Billi; Emanual Maverakis; J Michelle Kahlenberg; Nicole L Ward; Johann E Gudjonsson Journal: Cell Mol Immunol Date: 2020-08-19 Impact factor: 11.530
Authors: Maximilian Christian Schielein; Linda Tizek; Barbara Schuster; Stefanie Ziehfreund; Tilo Biedermann; Alexander Zink Journal: Acta Derm Venereol Date: 2020-05-28 Impact factor: 3.875